Displaying drugs 226 - 250 of 389 in total
Mercury Acetate Ion
Experimental
3,9-Dimethyladenine
Experimental
Tricarbonyl(1,10-phenanthroline)rhenium(1+)
Experimental
4-Fluorobenzylamine
Experimental
Dithiazanine
Dithiazanine is a highly potent anthelmintic, introduced in 1959 for the treatment of strongyloid worms and whipworms. However, its use is severely limited due to its toxicity. Dithiazanine iodide was associated with eight fatal cases of severe acidosis and shock between 1961 and 1964. Dithiazanine iodide has been withdrawn from...
Vet approved
Withdrawn
Prifinium
Prifinium is an antimuscarinic agent with antispasmodic and antiemetic properties. It may be useful for the treatment of irritable bowel syndrome .
Experimental
Tridihexethyl
Tridihexethyl is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract. Tridihexethyl is an antimuscarinic, anticholinergic drug. Tridihexethyl is no longer available in the US market.
Withdrawn
Strontium malonate
Strontium malonate is being developed as a novel orally available pharmaceutical for the treatment and prevention of osteoporosis. It is being developed by Osteologix Inc.
Investigational
Bibrocathol
Experimental
Distigmine
Distigmine is a parasympathomimetic agent with a longer duration of action and enhanced drug accumulation compared to DB00545 and DB01400. It is an anticholinergic drug and long-acting reversible carbamate cholinesterase inhibitor that binds directly and competitively to the agonist binding sites of muscurinic receptors. Distigmine is available in several countries...
Experimental
3-Methylcytosine
Experimental
4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium
Experimental
4-Iodobenzo[B]Thiophene-2-Carboxamidine
Experimental
Benzoxonium
Experimental
Histidinol
Experimental
Bibenzonium
Experimental
Lithium succinate
Experimental
Chromic citrate
Experimental
Displaying drugs 226 - 250 of 389 in total